A femto future?

Article

The act of collaboration is generally regarded positively. Uniting two parties that share a common interest usually yields achievements that could not have been possible if either party went at it alone, and so the whole becomes greater than the sum of the parts.

The act of collaboration is generally regarded positively. Uniting two parties that share a common interest usually yields achievements that could not have been possible if either party went at it alone, and so the whole becomes greater than the sum of the parts.

Certainly, this was the thinking behind Schwind and Bausch & Lomb’s recent strategic moves, which resulted in collaborations with established femtosecond laser manufacturers for the two firms. Both companies had already cemented their reputation in the laser refractive surgery market, although one key ingredient was missing from both: the technology that has created a big buzz around the ophthalmology community - the femtosecond laser. The all-LASIK solution that both Schwind and Bausch & Lomb are now able to offer is something that many surgeons and even patients are now requesting.

Despite its growing popularity, the jury is still out on whether femtosecond technology is in fact a must for all refractive surgeons. While many ophthalmologists think that femtosecond technology is the decade’s most significant technological breakthrough, there are those who remain at best undecided and, at the more extreme end of the spectrum, even downright cynical. Particularly in the practice of laser refractive surgery, is a femtosecond laser really such an improvement over a mechanical microkeratome? Some believe not.

Whether refractive surgeons have signed up to the femtosecond fan club or not, today’s refractive surgery practice needs to appear to be at the forefront of technology in order to keep pace in this hugely competitive market. Because of the strong marketing messages and effective advertising campaigns transmitted by some refractive clinics, particularly in the US and Europe, it seems that in order to be, or to be perceived to be, “at the forefront of innovation”, today’s refractive surgery practice needs to jump on the femtosecond bandwagon. Coupled with the expanding indications now being assessed for this technology, there is no way for the femtosecond technology market to go in the next few years other than up.

Best wishes,

Fedra PavlouEditorfpavlou@advanstar.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.